Dysport in Hallux Abducto Valgus (HAV) Phase IIa
NCT03569098
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
186
Enrollment
INDUSTRY
Sponsor class
Conditions
Hallux Abducto Valgus
Interventions
BIOLOGICAL:
Botulinum toxin type A
DRUG:
Placebo
Sponsor
Ipsen